Treating inflammation: should we bother?

Ian Balfour-Lynn (London, United Kingdom)

Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas
Session: Cystic fibrosis in children and adults: treatment dilemmas
Session type: Symposium
Number: 3376
Disease area: Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ian Balfour-Lynn (London, United Kingdom). Treating inflammation: should we bother?. International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cough dysfunction: What to measure? When to treat?
Source: Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease
Year: 2008



Infection: friend or foe to the development of asthma?
Source: Eur Respir J 2001; 18: 744-747
Year: 2001


Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - PRO
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011


Complex lung function in severe asthma: seeing is believing
Source: Eur Respir J 2016; 48: 294-296
Year: 2016


Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007

Mild persistent asthma: to treat or not to treat regularly?
Source: ERS Live 2007
Year: 2007


Neutrophilic inflammation: "Don't you go to pieces on me!"
Source: Eur Respir J 2006; 28: 257-258
Year: 2006


Chronic breathlessness: symptom or syndrome?
Source: Eur Respir J, 49 (5) 1700366; 10.1183/13993003.00366-2017
Year: 2017



Inflammation: friend or foe of muscle remodelling in COPD?
Source: Eur Respir J 2007; 30: 605-607
Year: 2007


Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Source: Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019
Year: 2019



Persistent atelectasis: then what?
Source: Annual Congress 2010 - Paediatric Grand Round: an interactive session
Year: 2010


Does inflammation help during COVID-19?
Source: ERJ Open Res, 6 (4) 00557-2020; 10.1183/23120541.00557-2020
Year: 2020



Update on severe asthma: what we know and what we need
Source: Eur Respir Rev 2009; 18: 58-65
Year: 2009


Pulmonary lesion(s) associated with neurological symptoms: what to do?
Source: Eur Respir J 2005; 26: Suppl. 49, 320s
Year: 2005

COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - CON
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011